MedPath

Aschistosoma Haematobiumspecific microRNAas a Tumor Marker for Early Diagnosis and Prognosis of Bilharzial Bladder Cancer in Eygpt

Not Applicable
Not yet recruiting
Conditions
Bladder Cancer
Interventions
Diagnostic Test: urinary micro RNA detection
Registration Number
NCT05697224
Lead Sponsor
Sohag University
Brief Summary

miRNAs have been detected in different bodily fluids, which suggests significant potential, such as their use as biomarkers in diagnostics and prognostics. Sha-mir-71a was abundantly found in the urine of patients with bladder cancer as compared to benign bladder cystitis associated with schistosomiasis . Additionally, this miRNA was more highly detected in urine samples from patients with bilharzial bladder cancer than bladder cancer not associated with bilharziasis (schistosomiasis), suggesting its specificity in the identification of bladder cancer associated with infection.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • urinary symptoms (hematuria, urinary retention, dysuria... etc.), who were planned to undergo cystoscopy for suspicion of bladder cancer (BC) or benign bilharzial cystitis (Bil), will be selected.
Read More
Exclusion Criteria
  • : In bladder cancer group Patients who have received chemotherapy, or with previously diagnosed other malignancy within the past 5 years.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
chronicurinary schistosomiasisurinary micro RNA detection-
bladder cancer diseased patientsurinary micro RNA detection-
Primary Outcome Measures
NameTimeMethod
use micro RNAas adiagnostic test for early diagnosis of shistosomal bladder cancerone year

Sha-mir-71a could be a biomarker with diagnostic and prognostic value

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath